Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Curing Hepatitis C Could Yield Huge Economic Benefit

May 18, 2015 11:07 am | News | Comments

While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released at Digestive Disease Week (DDW) 2015. Read more...


Anemia Distorts Regular Method of Diabetes Diagnosis

May 18, 2015 9:23 am | by University of Nottingham | News | Comments

Scientists have found that the blood condition anemia can lead to a false diagnosis of diabetes. Read more...


GSK Study Shows Link Between Improving Health Status and Reduced Mortality in COPD Patients

May 18, 2015 9:13 am | News | Comments

The primary objectives of COPD treatment are to enable patients to effectively manage their disease, improve their health status and slow the rate of decline from this chronic and progressive disease. Read more...


New Tool Will Lead to More Relevant Clinical Trials

May 18, 2015 9:01 am | by University of Abderdeen | News | Comments

A huge number of clinical trials are poorly designed and as such the results they produce can be irrelevant to real end users. Read more...


Astellas Announces New Data from Phase 3 Study for OAB Drug

May 18, 2015 8:53 am | News | Comments

The results of the trial showed that the add-on group achieved its primary efficacy endpoints. Read more...


Lives Could Be Saved with New Hepatitis C Therapy

May 18, 2015 8:37 am | by Monash University | News | Comments

Hepatitis C virus infection is a major public health burden in Australia, with estimates of 230,000 people chronically infected. Read more...


Tuberculosis Drug Can Improve CBT Efficacy

May 18, 2015 8:31 am | by Karolinska Institutet | News | Comments

A new study shows that the effect of internet-based CBT (cognitive behavioural therapy) for people with people with obsessive-compulsive disorder (OCD) may be boosted with a drug called d-cycloserine, which has long been used to treat TB. Read more...


Specialty Drugs Spotlight: The Week’s Top Pharma News

May 15, 2015 2:25 pm | by Stephanie Guzowski, Editor | News | Comments

From pharma collaborations on therapies to fallouts over failed clinical trials, here are your headlines this week. Read more...


Trial Explores Rivaroxaban in Catheter Ablation

May 15, 2015 1:01 pm | News | Comments

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced results from the VENTURE-AF trial. The study explored the potential of once-daily Xarelto (rivaroxaban) as an alternative to vitamin K antagonists (VKA), used to reduce the risk of blood clots, in people with non-valvular atrial fibrillation (NVAF) undergoing catheter ablation. Read more...


Tonix Pharmaceuticals Launches Phase 3 Study in Fibromyalgia

May 15, 2015 12:53 pm | News | Comments

Tonix Pharmaceuticals Holding Corp. announced that it has begun a Phase 3 clinical study of TNX-102 SL (cyclobenzaprine HCl sublingual tablet, 2.8 mg) in fibromyalgia, having recently randomized the first patient. The study is expected to enroll approximately 500 patients with fibromyalgia at approximately 35 clinical centers in the U.S. Read more...


Vitamin D Levels Help Predict Survival of Sick Cats

May 15, 2015 12:48 pm | by Bevin Fletcher, Associate Editor | News | Comments

Vitamin D could give your sickly feline friend its 10th life, according to a recent study. New research from the University of Edinburgh found that higher levels of vitamin D were linked to increased survival changes for hospitalized cats. Read more...


Early Obesity Research Finds Leptin Hormone May Not Be Overeating Culprit

May 15, 2015 12:42 pm | by University of Cincinnati | News | Comments

For years, scientists have pointed to leptin resistance as a possible cause of obesity. Research led by investigators at the University of Cincinnati (UC) Metabolic Diseases Institute, however, found that leptin action isn't the culprit. Read more...


Airborne Ebola Threat Analyzed by Scientists

May 15, 2015 12:22 pm | by Seth Augenstein, Digital Reporter | News | Comments

The cross-ocean panic that accompanied the spread of Ebola in Western Africa was fueled by the unthinkable: the worst-case scenario that the dreaded virus could go airborne. No need to worry, according to a team of University of Florida researchers, who have analyzed decades of the virus’s known evolution. Read more...


U.S. Court Halts Contentious Law on Contact Lens Price-Fixing

May 15, 2015 12:10 pm | by Lindsay Whitehurst - Associated Press | News | Comments

A federal appeals court has halted a new Utah law banning price-fixing for contact lenses that could have wide-ranging implications for the industry amid a fight between manufacturers and discount retailers. Read more...


PharmaMar Announces New Oncology Advances with Yondelis, PM1183 Compounds

May 15, 2015 9:18 am | News | Comments

The studies were selected for oral discussion session and poster presentation at the American Society of Clinical Oncology's meeting later this month. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.